See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus

Helgi Silm

https://www.etis.ee/CV/Helgi_Silm/est
731 9700
helgi.silm@ut.ee

Teenistuskäik

Töökohad ja ametid
01.09.2010–...   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, Dermatoloogia ja veneroloogia õppetool, Emeriitprofessor (1,00)
01.01.2016–31.08.2017   
Tartu Ülikool, Meditsiiniteaduste valdkond, kliinilise meditsiini instituut, dermatoloogia ja veneroloogia vanemteadur (0,50)
01.09.2014–31.12.2015   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, dermatoloogia ja veneroloogia vanemteadur (0,50)
01.09.2011–31.08.2014   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, dermatoloogia ja veneroloogia vanemteadur (0,50)
01.09.2008–31.08.2010   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, dermatoloogia ja veneroloogia professor (0,50)
01.09.2008–31.08.2011   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, vanemteadur (0,50)
01.09.2008–31.08.2010   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, kliiniku juhataja
01.09.2005–31.08.2008   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, kliiniku juhataja
01.09.2003–31.08.2008   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, dermatoloogia ja veneroloogia professor (1,00)
01.09.2002–31.08.2005   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, kliiniku juhataja
 
 
Haridustee
TRÜ Astiteaduskond 1960 - 1966
TRÜ Aspirantuur 1966 - 1971
 
 
Teadusorganisatsiooniline ja -administratiivne tegevus
2006−...   
Eesti Naha- ja Suguhaiguste Arstide Seltsi juhatuse liige
1993−...   
SA Tartu Ülikooli Kliinikum, Nahahaiguste kliiniku juhataja
Balti Dermatoveneroloogide Assotsiatsiooni asepresident,
Euroopa Dermatovenereoloogide Assotsiatsiooni (EADV) liige,
Maailma STD/HIV Teadusliku Seltsi liige,
Kesk ja Ida Euroopa Dermatoveneroloogide Assotsiatsiooni liige,
Meditsiinitöötajate Euroopa Ühingu (UEMS) liige,
Euroopa Dermatoveneroloogide Foorumi (EDF) liige
Sugulisel Teel Levivate Haiguste Eesti Ühingu liige,
Eest Vabariigi Sotsiaalministeeriumi Dermatoveneroloogia Erialakomisjoni liige,
Eesti Dermatoveneroloogide Atestatsioonikomisjoni esimees,
Soome Dermatoveneroloogide Seltsi auliige.
Itaalia dermatoloogide ja esteetilise kirurgide seltsi auliige
Erialaseltsi presidendina olen korraldanud igal aastal neli (4) eralast
Balti Dermatoveneroloogide Assotsiatsiooni asepresidendina organiseerin Balti Dermatoveneroloogide kongresse
1984−2010   
TÜ Arstiteaduskonna Nõukogu liige

Kvalifikatsioon

Teaduskraadid
Helgi Silm, doktorikraad, 1971, (juh) -, Naha funktsionaalse seisundi,vereseerumi katehoolamiinideja koliinesteraasi aktiivsuse muutustest epiderma-ja trihhomükoosi haigeil, Tartu Ülikool.
 
 
Lisainfo
Meditsiini kandidaat
TRÜ, 16. detsember 1971. a.,
diplom väljastati Moskvas Üleliidulise Atestatsioonikomitee poolt 1972.

Lõppenud projektid

Juhendatud väitekirjad

Publikatsioonid

Klass
Aasta
Publikatsioon
 
1.1.
2016
Traks, Tanel; Karelson, Maire; Reimann, Ene; Rätsep, Ranno; Silm, Helgi; Vasar, Eero; Kõks, Sulev; Kingo, Külli (2016). Association analysis of class II cytokine and receptor genes in vitiligo patients. Human Immunology, 77 (5), 375−381.10.1016/j.humimm.2015.09.050.
1.2.
2016
Reimann, Ene; Kingo, Külli; Karelson, Maire; Reemann, Paula; Vasar, Eero; Silm, Helgi; Kõks, Sulev (2016). Whole Transcriptome Analysis (RNA Sequencing) of Peripheral Blood Mononuclear Cells of Vitiligo Patients. Dermatopathology, 1 (1), 11−23. DOI: 10.1159/000357402.
1.1.
2015
Keermann, Maris; Kõks, Sulev; Reimann, Ene; Abram, Kristi; Erm, Triin; Silm, Helgi; Kingo, Külli (2015). Expression of IL-36 family cytokines and IL-37 but not IL-38 is altered in psoriatic skin. Journal of Dermatological Science, 80 (2), 150−152. DOI: 10.1016/j.jdermsci.2015.08.002.
1.1.
2014
Reemann, P.; Reimann, E.; Ilmjärv, S.; Porosaar, O.; Silm, H.; Jaks, V.; Vasar, E.; Kingo, K.; Kõks, S. (2014). Melanocytes in the skin - comparative whole transcriptome analysis of main skin cell types. PLoS ONE, 9 (12), e115717. DOI: 10.1371/journal.pone.0115717.
1.1.
2014
Reemann, Paula; Reimann, Ene; Suutre, Siim; Paavo, Maarjaliis; Loite, Ulvi; Porosaar, Orm; Abram, Kristi; Silm, Helgi; Vasar, Eero; Koks, Sulev; Kingo, Kuelli (2014). Expression of Class II Cytokine Genes in Children's Skin. Acta Dermato Venereologica, 94 (4), 386−392. DOI: 10.2340/00015555-1717.
1.1.
2013
Karelson, M.; Silm, H.; Kingo, K. (2013). Quality of Life and Emotional State in Vitiligo in an Estonian Sample: Comparison with Psoriasis and Healthy Controls. Acta Dermato Venereologica, 93, 446−450.
1.1.
2013
Prans, Ele; Kingo, Külli; Traks, Tanel; Silm, Helgi; Vasar, Eero; Kõks, Sulev (2013). Copy number variations in IL22 gene are associated with psoriasis vulgaris. Human Immunology, 74 (6), 792−795.10.1016/j.humimm.2013.01.006.
1.1.
2013
Loite, U; Kingo, K; Reimann, E; Reemann, P; Vasar, E; Silm, H; Kõks, S. (2013). Gene Expression Analysis of the Corticotrophin-releasing Hormone-proopiomelanocortin System in Psoriasis Skin Biopsies. Acta Dermato Venereologica, 93 (4), 400−405. DOI: 10.2340/00015555-1524.
1.1.
2012
Karelson, M.; Silm, H.; Kingo, K. (2012). Quality of Life and Emotional State in Vitiligo in an Estonian Sample: Comparison with Psoriasis and Healthy Controls. Acta Dermato Venereologica, 00.
1.1.
2012
Karelson, M.; Silm, H.; Salum, T.; Kõks, S.; Kingo, K. (2012). Differences between familial and sporadic cases of vitiligo. Journal of the European Academy of Dermatology and Venereology, 26 (7), 915−918. DOI: 10.1111/j.1468-3083.2011.04131.x.
1.1.
2012
Douroudis, K.; Kingo, K.; Traks, T.; Reimann, E.; Raud, K.; Rätsep, R.; Mössner, R.; Silm, H.; Vasar, E.; Kõks, S. (2012). Polymorphisms in the ATG16L1 Gene are Associated with Psoriasis Vulgaris. Acta Dermato Venereologica, 92 (1), 85−87. DOI: 10.2340/00015555-1183.
1.1.
2012
Reimann, E.; Kingo, K.; Karelson, M.; Reemann, P.; Loite, U.; Sulakatko, H.; Keermann, M.; Raud, K.; Abram, K.; Vasar, E.; Silm, H.; Kõks, S. (2012). The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells. Human Immunology, 73 (4), 393−398. DOI: 10.1016/j.humimm.2012.01.011.
1.1.
2012
Reimann, E.; Kingo, K.; Karelson, M.; Reemann, P.; Loite, U.; Keermann, M.; Abram, K.; Vasar, E.; Silm, H.; Kõks, S. (2012). Expression profile of genes associated with the dopamine pathway in vitiligo skin biopsies and blood sera. Dermatology, 224 (2), 168−176. DOI: 10.1159/000338023.
4.2.
2012
Altmets, Mait; Altraja, Alan; Ambos, Anu; Andresen, Kadri; Arumäe, Katrin; Brachinsky, Mark; Elmet, Märt; Haldre, Sulev; Hedman, Anu; Kahu, Jaanus; Kaljusaar, Heli; Kallikorm, Riina; Karelson, Maire; Karjagin, Juri; Kaur, Sirje; Kingo, Külli; Koorits, Ursula; Kull, Karin; Kõrv, Janika; Linnamägi, Ülla ... Uuetoa, Tiina (2012). Eakate farmakoteraapia. Tallinn: Medicina.
5.2.
2012
Karelson, M.; Silm, H.; Kingo, K. (2012). Vitiliigohaigete elukvaliteedi ja emotsionaalse seisundi võrdlus psoriaasihaigete ning tervete vabatahtlikega. Eesti Arst: TÜ arstiteaduskonna aastapäeva teaduskonverents, Tartu, oktoober 2012. 23−23.
1.1.
2011
Douroudis, K.; Kingo, K.; Traks, T.; Rätsep, R.; Silm, H.; Vasar, E.; Kõks, S. (2011). ATG16L1 gene polymorphisms are associated with palmoplantar pustulosis. Human Immunology, 72 (7), 613−615.
1.1.
2011
Douroudis, K.; Kingo, K.; Karelson, M.; Silm, H.; Reimann, E.; Traks, T.; Vasar, E.; Kõks, S. (2011). The PRO2268 gene as a novel susceptibility locus for vitiligo. Acta Dermato Venereologica, 91 (2), 189−191. DOI: 10.2340/00015555-0999.
5.2.
2011
Karelson, Maire; Silm, Helgi; Salum, Tiit; Kõks, Sulev; Kingo, Külli (2011). Differences between familial and sporadic cases of vitiligo. Eesti Arst: Arstiteaduskonna päevad, Tartu, 13-14.okt.2011. 22−22. (90, lisa1).
1.1.
2010
Douroudis, K.; Kingo, K.; Silm, H.; Reimann, E.; Traks, T.; Vasar, E.; Kõks, S. (2010). The CD226 Gly307Ser gene polymorphism is associated with severity of psoriasis. Journal of Dermatological Science, 58, 160−161. DOI: 10.1016/j.jdermsci.2010.03.015.
1.1.
2010
Kõks, Sulev; Kingo, Külli; Mössner, Rotraut; Rätsep, Ranno; Krüger, Ullrich; Silm, Helgi; Vasar, Eero; Reich, Kristian; Raud, Kristi; Traks, Tanel; Reimann, Ene (2010). Further association analysis of chr 6q22-24 suggests a role of IL-20RA polymorphisms in psoriasis. Journal of Dermatological Science, 57 (1), 71−73. DOI: 10.1016/j.jdermsci.2009.10.007.
1.1.
2010
Kingo, K.; Reimann, E.; Karelson, M.; Rätsep, R.; Raud, K.; Vasar, E.; Silm, H.; Kõks, S. (2010). Association analysis of genes of the IL19 cluster and their receptors in vitiligo patients. Dermatology, 221 (3, 10), 261−266. DOI: 10.1159/000317526.
1.1.
2010
Philips, M-A; Kingo, K; Karelson, M; Rätsep, R; Aunin, E; Reimann, E; Reemann, P; Porosaar, O; Vikeså, J; Nielsen, F; Vasar, E; Silm, H; Kõks, S. (2010). Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1. BMC Medical Genetics, 56. DOI: 10.1186/1471-2350-11-56.
1.1.
2010
Reimann, E.; Kingo, K.; Karelson, M.; Salum, T.; Aunin, E.; Reemann, P.; Abram, K.; Vasar, E.; Silm, H.; Kõks, S. (2010). Analysis of the expression profile of CRH-POMC system genes in vitiligo skin biopsies. Journal of Dermatological Science, 60 (2), 125−128. DOI: 10.1016/j.jdermsci.2010.08.004.
1.1.
2010
Abram, K.; Silm, H.; Maaroos, HI.; Oona, M. (2010). Risk factors associated with rosacea. Journal of the European Academy of Dermatology and Venereology, 24 (5), 565−571. DOI: 10.1111/j.1468-3083.2009.03472.x.
1.1.
2010
Abram, K.; Silm, H.; Oona, M. (2010). Prevalence of rosacea in an Estonian working population using a standard classification. Acta Dermato Venereologica, 90 (3), 269−273. DOI: 10.2340/00015555-0856.
5.2.
2010
Reimann, E.; Reemann, P.; Lilleoja, R.; Jaakma, Ü.; Kingo, K.; Vasar, E.; Silm, H.; Kõks, S. (2010). Whole transcriptome RNA-Seq of human dermal fibroblasts using SOLiD system. CRG Symposium: "Medical Genome Sequencing: Understanding the Genomes of Disease", Barcelona, Spain, 28.-29.10.2010.
6.2.
2010
Kaur, Sirje; Silm, Helgi; Kingo, Külli; Karelson, Maire; Abram, Kristi. (2010). Nahahaigused. Eesti, Tartu ülikooli kirjastus: University of Tartu.
1.1.
2009
Abram, K.; Silm, H.; Maaroos, H.-I.; Oona, M. (2009). Subjective disease perception and symptoms of depression in relation to healthcare-seeking behaviour in patients with rosacea. Acta Dermato Venereologica, 89 (5), 488−491.
1.2.
2009
Karelson, M.; Kingo, K.; Salum, T.; Kõks, S.; Silm, H. (2009). An Adult´s Vitiligo in Estonia: Study of 155 patients. The Open Dermatology Journal, 3, 68−72.
5.1.
2009
Abram, K.; Silm, H.; Maaroos, H.-I.; Oona, M. (2009). Risk Factors Associated for Rosacea. Helicobacter, 14: 22nd International Workshop on Helicobacter and Related Bacteria in Chronic Digestive Inflammation and Gastric Cancer, SEP 17-19, 2009 Opotro, PORTUGAL. 367. (4).
5.1.
2009
Abram, K.; Silm, H.; Maaroos, HI. (2009). Risk factors associated with rosacea. Helicobacter 14(4): 22nd International Workshop on Helicobacter and Related Bacteria in Chronic Digestive Inflammation and Gastric Cancer; Opotro, Portugal; 17-19, September 2009. 367.
5.2.
2009
Abram, K.; Silm, H.; Maaroos, H.-I.; Oona, M. (2009). Rosaatseaga seotud riskifaktorid. Eesti Arst, 88: TÜ Arstiteaduskonna päevad 2009, Dorpati konverentsikeskus, 8-9 oktoober.. 621. (9).
5.2.
2009
Abram, K.; Silm, H.; Oona, M. (2009). Prevalence of rosacea in general population according to the national rosacea society expert committee. 90: Final Programme 6th EADV Spring Symposium; Bucharest, Romania; April 23-26, 2009. 269−273.
1.1.
2008
Kingo, K.; Aunin, E.; Karelson, M.; Rätsep, R.; Silm, H.; Vasar, E.; Kõks, S. (2008). Expressional changes in the intracellular melanogenesis pathways and their possible role in the pathogenesis of vitiligo. Journal of Dermatological Science, 52 (1), 39−46. DOI: 10.1016/j.jdermsci.2008.03.013.
1.1.
2008
Kingo, K.; Mössner, R.; Rätsep, R.; Raud, K.; Krüger, U.; Silm, H.; Vasar, E.; Reich, K.; Kõks, S. (2008). Association analysis of IL20RA and IL20RB genes in psoriasis. Genes and Immunity, 9 (5), 445−451. DOI: 10.1038/gene.2008.36.
1.1.
2008
Rätsep, R.; Kingo, K.; Karelson, M.; Reimann, E.; Raud, K.; Silm, H.; Vasar, E.; Kõks, S. (2008). Gene expression study of IL10 family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera. British Journal of Dermatology, 159 (6), 1275−1281. DOI: 10.1111/j.1365-2133.2008.08785.x.
1.3.
2008
Kangur, A.; Põder, A.; Maimets, M.; Silm, H.; Kukk, T.; Uusküla, A.; Rajangu, H.; Brilene, T.; Zilmer, K.; Saarma, I.; Karro, H.; Tammemäe, L.; Szirko, F.; Timberg, G.; Punab, M.; Kallikorm, R. (2008). STList vallandunud reaktiivne artriit. Eesti Arst, 87 (3), 231−241.
5.1.
2008
Abram, K.; Oona, M.; Silm, H.; Maaroos, H.-I. (2008). Trends of the Prevalence of H. pylori in Adults in Estonia. Helicobacter, 13: 1st International Workshop on Helicobacter and Related Bacteria in Chronic Digestive Inflammation and Gastric Cancer; Riga, LATVIA; SEP 18-20, 2008. 429. (5).
5.2.
2008
Karelson, M.; Kingo, K.; Silm, H. (2008). Vitiliigo kliinilised vormid ja nende avaldumine. Eesti Arst, 87: TÜ Arstiteaduskonna päevad; Tartu; 9-10.okt 2008. OÜ Celsius Healthcare, 668−668. (9).
5.2.
2008
Abram, K.; Oona, M.; Maaroos, H.-I.; Silm, H. (2008). Depressive symptoms and disease perception among rosacea patients. 17th Congress of the European Academy of Dermatology and Venerology (EADV 2008); Paris; 17-21 September 2008.
5.2.
2008
Abram, K.; Oona, M.; Maaroos, H.-I.; Silm, H. (2008). Helicobacter pylori infektsiooni levimus täiskasvanutel. Eesti Arst, 87(9): TÜ Arstiteaduskonna teaduskonverents, 09.10.2008 Tartu. 674.
6.7.
2008
Silm, Helgi; Kõks, Sulev; Kingo, Külli; Rätsepp, Ranno; Kaur, Sirje; Abram, Kristi; Pärna, Ene; Kingo, Külli; Karelson, Maire (2008). Kliinik 2008 : psoriaasi patogenees ja ravi - kaasaegsed arengusuunad TÜ Nahahaiguste Kliinikus [Videosalvestis]. Kliinik 2008, Tartu Ülikooli Kliinikumi täienduskonverents; Tartu; 4. - 6. veebruar, 2008. Tartu: TÜ IT Multimeedia talitus,. (TÜ filmiarhiiv).
1.1.
2007
Kingo, K.; Mossner, R.; Koks, S.; Ratsep, R.; Kruger, U.; Vasar, E.; Reich, K.; Silm, H. (2007). Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis. British Journal of Dermatology, 156 (4), 646−652. DOI: 10.1111/j.1365-2133.2006.07731.x.
1.1.
2007
Kingo, K.; Aunin, E.; Karelson, M.; Philips, MA; Rätsep, R.; Silm, H.; Vasar, E.; Soomets, U.: Kõks S. (2007). Gene expression analysis of melanocortin system in vitiligo. Journal of Dermatological Science, 48 (2), 113−122.
1.3.
2007
Kangur, A.; Põder, A.; Maimets, M.; Silm, H.; Kukk, T.; Uusküla, A.; Rajangu, H.; Brilene, T.; Zilmer, K.; Saarma, I.; Karro, H.; Tammemäe, L.; Szirko, F.; Timberg, G.; Punab, M.; Kallikorm, R. (2007). Seksuaalsel teel levivate infektsioonide Eesti ravijuhend 2007. I. Omandatud süüfilis. Eesti Arst, 86 (10), 770−777.
1.3.
2007
Abram, K.; Oona, M.; Silm, H. (2007). Rosaatsea ja perioraalne dermatiit. Eesti Arst, 86 (10), 729−735.
3.2.
2007
Kõks, S.; Kingo, K.; Vasar, E.; Silm, H. (2007). Interleukin-20. In: Zdanov, A. (Ed.). Class II Cytokines (145−160).. Research Signpost.
5.2.
2007
Karelson, M.; Kingo, K.; Kõks, S.; Silm, H.; Vasar, E.; Salum, T. (2007). Coexistence of vitiligo and autoimmune disorders in Estonia. Abstract Book: 21 World Congress of Dermatology, Buenos Aires, Argentina, 01-05.oct,2007. 344.
5.2.
2007
Kingo, K.; Raud, K.; Rätsep, R.; Kõks, S.; Silm, H.; Vasar, E. (2007). The gene expression of Interleukin-22 in plaque psoriasis. Abstract Book: 21 World Congress of Dermatology; Buenos Aires, Argentina; 01-05.oct. 2007. 203.
5.2.
2007
Karelson, M.; Kingo, K.; Kõks, S.; Vasar, E.; Salum, T.; Silm, H. (2007). Autoimmuunhaiguste kaasnemine ja autoantikehade esinemine vitiliigo haigetel. Eesti Arst, 86, 691.
5.2.
2007
Pärna, E.P.; Abram, K.; Kingo, K.; Oona, M.; Silm, H. (2007). Emotional status in psoriasis patients in relation to the sevsrity of disorder. 12th Congress of the European Society for Dermatology and Psychiatry, Wroclaw, Poland, June 14th-17th, 2007. 46.
5.2.
2007
Pärna, E.; Abram, K.; Kingo, K.; Oona, M.; Silm, H. (2007). Psoriaasihaigete emotsionaalne enesetunne sõltuvalt haiguse raskusest. Eesti Arst, 689−690.
5.2.
2007
Abram, K.; Oona, M.; Silm, H.; Maaroos, H.-I. (2007). Rosaatsea seosed Helicobacter pylori infektsiooniga. Eesti Arst, 86: Õppejõudude, teadurite, doktorantide, magistrantide ja üliõpilaste teaduskonverents 18. oktoobril 2007 TÜ Biomeedikumis. Eesti Arst, 675. (9).
1.1.
2006
Kingo, K.; Philips, M.A.; Aunin, E.; Luuk, H.; Karelson, M.; Ratsep, R.; Silm, H.; Vasar, E.; Kõks, S. (2006). MYG1, novel melanocyte related gene, has elevated expression in vitiligo. Journal of Dermatological Science, 44 (2), 119−122.
1.3.
2006
Karelson, M.; Kingo, K.; Silm, H. (2006). Vitiliigo - mis on teada tänasel päeval? Eesti Arst, 85 (7), 438−444.
3.1.
2006
Kõks, S.; Kingo, K.; Vasar, E.; Silm, H. (2006). Interleukin-19 subfamily of cytokines. In: Vandenbroeck, K. (Ed.). Cytokine Gene Polymorphisms in Multifactorial Conditions (147−155).. CRC Press Inc.
3.1.
2006
Kõks, S.; Kingo, K.; Vasar, E.; Silm, H. (2006). Psoriasis and cytokine polymorphisms. In: Vandenbroeck, K. (Ed.). Cytokine Gene Polymorphisms in Multifactorial Conditions (321−335).. CRC Press Inc.
3.4.
2006
Abram, K.; Silm, H.; Oona, M. (2006). Smoking habits among patients with Rosacea. From Hippocrates to Modern Dermatology 15th EADV Congress; Rhodes, Greece; 4-8 October, 2006. Mediamond, 639−642.
5.2.
2006
Silm, H. (2006). Update in Treatment of Pyoderma. Precise diagnostics - foundation for a succesful skin and STD theray: BADV 6th Congress; Läti, Riia; 14 - 16 september 2006. _EditorsAbbr Rubins, A. Läti: Latvia, 30.
5.2.
2006
Kingo, K.; Karelson, M.; Aunin, E.; Silm, H.; Vasar, E.; Kõks, S. (2006). Regulation of the cutaneous corticotropin releasing hormone - proopiomelanocortin systemin vitiligo. BADV 6th Congress; Latvia, Riga; 14 - 16 September, 2006. Ed. Rubins, A. Läti, Riia: Latvia, 41.
5.2.
2006
Kingo, K.; Karelson, M.; Aunin, E., Kõks, S.; Vasar, E.; Silm, H. (2006). Expression of Genes of Melanocortin system in Vitiligo. Dermatovenerologie, 51 (3): National Congress of Dermatology with Intyernational Participation. The XIIth ALP-Danube-Adria STD conference; 1- 4 november, 2006. Rumeenia, 2. (Suppl. 1).
5.2.
2006
Rätsep, R.; Karelson, M.; Kingo, K.; Aunin, E.; Kõks, S.; Silm, H.; Vasar, E. (2006). Interleukiinide ja nende retseptorite ekspressioon vitiliigoga patsientide ja kontrollgrupi nahas. Eesti Arst, 85(9): TÜ arstiteaduskonna teaduskonverents; Tartu; 13. oktoober 2006. 618.
5.2.
2006
Philips, M.-A.; Kingo, K.; Kõks, S.; Aunin, E.; Karelson, M.; Silm, H.; Vasar, E. (2006). Myg1 protein is functionally important in both brain and skin. FENS Forum Abstracts, 3: 5th Forum of European Neuroscience; Vienna, Austria; 08 - 12 July, 2006.
5.2.
2006
Raud, K.; Kingo, K.; Ehrlich, K.; Kõks, S.; Silm, H.; Vasar, E.; Soomets, U. (2006). Glutatsioonisüsteemi regulatsioon psoriaasi korral. Eesti Arst, 85 (9): Arstiteaduskonna päevad 2006. 633−634.
5.2.
2006
Kingo, K.; Aunin, E.; Karelson, M.; Rätsep, R.; Philips, M.A.; Luuk, H.; Kõks, S.; Silm, H.; Vasar, E. (2006). Melanokortiini - süsteem ja vitiliigo. Eesti Arst, 85 (9): TÜ arstiteaduskonna teaduskonverents; Tartu; 13.10.2006. , 647.
6.3.
2006
Silm, H. (2006). Morfea ehk Scleroderma circumscripta. Lege Artis, 25−26.
1.1.
2005
Mossner, R.; Kingo, K.; Kleensang, A.; Kruger, U.; Konig, IR.; Silm, H.; Westphal, GA.; Reich, K. (2005). Association of TNF-238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris. The Journal of Investigative Dermatology, 124 (1), 282−284.
1.1.
2005
Koks, S.; Kingo, K.; Vabrit, K.; Ratsep, R.; Karelson, M.; Silm, H.; Vasar, E. (2005). Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis. Genes and Immunity, 6 (5), 407−415.
1.1.
2005
Kingo, K.; Ratsep, R.; Koks, S.; Karelson, M.; Silm, H.; Vasar, E. (2005). Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility. Journal of Dermatological Science, 37 (2), 111−113.
1.1.
2004
Koks, S.; Kingo, K.; Ratsep, R.; Karelson, M.; Silm, H.; Vasar, E. (2004). Combined haplotype analysis of the interleukin-19 and-20 genes: relationship to plaque-type psoriasis. Genes and Immunity, 5 (8), 662−667.
1.1.
2004
Kingo, K.; Koks, S.; Nikopensius, T.; Silm, H.; Vasar, E. (2004). Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis. Genes and Immunity, 5 (2), 117−121.
1.1.
2004
Järv, H.; Naaber, P.; Kaur, S.; Eisen, M.; Silm, H. (2004). Screening of toenail onychomycosis in Estonia. Mycoses, 47, 57−61.
1.3.
2004
Kukk, T.; Raudsepp, H.; Tampere, M.; Skalkina, A.; Aluoja, A.; Kirsimägi, Ü.; Silm, H. (2004). Raske akne ravi süsteemse retinoidiga (isotretinoinum). Emotsionaalse enesetunde muutumine ravi käigus. Eesti Arst, 83 (10), 659−665.
5.2.
2004
Rätsep, R.; Kingo, K.; Kõks, S.; Karelson, M.; Silm, H.; Vasar, E. (2004). Interleukiin-19 ja interleukiin-20 geenide haplotüüpide efektid psoriaasi avaldumisele. 625.
5.2.
2004
Kingo, K.; Rätsep, R.; Kõks, S.; Karelson, M.; Silm, H.; Vasar, E. (2004). Genetic influence on IL-10 expression of patients with plaque type psoriasis. Journal of the European Academy of Dermatology and Venereology, 18 (Suppl. 2), 337.
5.2.
2004
Kingo, K.; Rätsep, R.; Kõks, S.; Karelson, M.; Silm, H.; Vasar, E. (2004). Association between interleukin-19 and interleukin-20 genetic polymorphisms and plaque-type psoriasis. 16th Congress of Latvian Association of Dermatovenerologists, "Latest Achievements in Skin and Sexually Transmitted Diseases Diagnostics and Therapy"; Riga, Latvia; September 10-11, 2004.
1.1.
2003
Kingo, K.; Koks, S.; Silm, H.; Vasar, E. (2003). IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes and Immunity, 4 (6), 455−457.
1.3.
2003
Volke, A.; Silm, H. (2003). Atoopiline dermatiit on enam kui lihtsalt allergia. Eesti Arst, 82 (6), 416−422.
3.1.
2003
Vasar, E.; Kõks, S.; Kingo, K.; Karelson, M.; Silm, H. (2003). Promoter polymorphism at position-592 of the interleukin-10 is not associated with early- and late-onset psoriasis. Journal of the European Academy of Dermatology and Venereology, 16, Supplement 1: 11th Congress of the European Academy of Dermatology and Venereology. 2-6 October 2002, Prague, Czech Republic. Bologna: Monduzzi Editore, 303−306.
3.3.
2003
Põder, A.; Maimets, M.; Silm, H.; Kangur, A.; Kukk, T.; Uusküla, A.; Rajangu, H. (2003). Seksuaalsel teel levivate infektsioonide ravijuhis Eestis. Tallinn: STLIEÜ.
3.4.
2003
Karelson, M.; Kürsa, V.; Kingo, K.; Silm, H. (2003). Teleangiectasia macularis eruptiva perstans. 11th Congress of the European Academy of Dermatology and Venereology; Prague, Czech Republic; 2-6 October 2002. 93−95.
5.2.
2003
Kingo, Külli; Kõks, Sulev; Silm, Helgi; Vasar, Eero (2003). Interleukiin-20 geneetiliste polümorfismide seos psoriaasiga. Eesti Arst, 9, 631.
5.2.
2003
Kingo, K.; Kõks, S.; Silm, H.; Vasar, E. (2003). Polymorphism in the promoter region of the interleukin-20 gene - relationship to psoriasis vulgaris. Journal of the European Academy of Dermatology and Venereology, 17, Suppl. 3, 378.
6.2.
2003
Kaur, S.; Silm, H. (2003). Nakkuslikud nahahaigused: õppevahend üliõpilastele ja arstidele. Tartu: Tartu Ülikooli Kirjastus.
6.6.
2003
Silm, H. (2003). Balti Dermatoveneroloogide Assotsiatsioon. Eesti Arst, 10, 736.
6.6.
2003
Silm, H.; Kingo, K. (2003). Esimesed kogemused psoriaasi ravimisel Daivobet salviga. Hippokrates, 45, 431−434.
1.1.
2002
Silm, H.; Karelson, M. (2002). Terbinafine: efficacy and tolerability in young children with tinea capitis due to Microsporum canis. Journal of the European Academy of Dermatology and Venereology, 16 (3), 228−230.
1.3.
2002
Silm, H.; Paasik, K.; Kingo, K.; Kink, R. (2002). Vaskaurude laser nahahaiguste ravis. Eesti Arst, 81 (7), 406−410.
1.3.
2002
Järv, H.; Naaber, P.; Kaur, S.; Eisen, M.; Silm, H. (2002). Varbaküünte seenhaigus Eestis - võrdlus Euroopa maadega. Eesti Arst, 81 (6), 338−342.
3.1.
2002
Silm, H.; Kerner, K.; Abram, K. (2002). Psychogenic Panniculitis in a 15-year-old Girl with Mental Retardion. Skin and Environment - Perception and Protection, 1-2: 10th Congress of the European Academy of Dermatology and Venereology; Munich, Germany; October 10-14, 2001. _EditorsAbbr Ring, J.; Weidinger, S.; Darsow, U. Bologna: Monduzzi Editore, 205−208.
3.2.
2002
Silm, H.; Karelson, M. (2002). Estonian Society for Dermatologists and Venereologists. In: Hercogova, J.; Delescluse, J.; Lotti, T.M. (Ed.). Millennium Dermatologicum. European handbook of Dermatological Societies (51−52). . Prague: Prague Academy.
3.4.
2002
Kingo, K.; Kõks, S.; Karelson, M.; Silm, H.; Vasar, E. (2002). Promoter polymorphism at position - 592 of the interleukin-10 is not associated with early and late-onset psoriasis. Proceedings 11th EADV Congress Prague 2002 “ More than Skin – deep” of the European Academy of Dermatology and Venerology, 16:1: Scientific Publishing&Communication. International Proceedings Division, 2003. 303−306.
3.4.
2002
Järv, H.; Naaber, P.; Kaur, S.; Eisen, M.; Silm, H. (2002). Clinical, mycological and epidemiological characteristics of toenail onychomycosis in Estonia. Clinical Microbiology and Infection, 8, Suppl. 1: 12th European Congress of Clinical Microbiology and Infectious Diseases; Milan, Italy; 21-24 Aprill 2002. 347−348.
3.5.
2002
Silm, H. (2002). Kaasasündinud süüfilis. Seksuaalsel Teel Levivate Infektsioonide Eesti ühingu IV konverents, Palmse; 14.-15. juuni 2002. Tallinn: STLIEÜ, 74−77.
5.2.
2002
Karelson, M.; Kürsa, V.; Kingo, K.; Silm, H. (2002). Teleangiectasia macularis eruptiva perstans. Journal of the European Academy of Dermatology and Venereology, 16, Suppl. 1: 11th Congress of the European Academy of Dermatology and Venereology. Brussels, 198.
5.2.
2002
Silm, H.; Kingo, K.; Paasik, K.; Kink, R. (2002). The efficiency of copper vapour laser equipment for treatment of patients with rosacea. Annales de Dermatologie et de Venereologie, 129, 1S615.
6.3.
2002
Abram, K.; Silm, H. (2002). Jalgade seenhaiguse ehk Tinea pedum'i ja seenallergiidide tänapäevane ravi. Lege Artis, 1, 5.
6.6.
2002
Silm, H. (2002). Terbinafiin küünte seenhaiguste ravis. Lege Artis, 6, 42−43.
6.6.
2002
Silm, H. (2002). Küüneseenhaiguse ravi laia toimespektriga antimükootikumidega. Lege Artis, 7 (11), 51.
6.6.
2002
Kaur, S.; Lehtmets, A.; Karelson, M.; Kukk, T.; Kangur, A.; Rajangu, H.; Põder, A.; Silm, H. (2002). Urtikaaria ravijuhend. Lege Artis, 10, 20−25.
1.1.
2001
Konno, P.; Silm, H. (2001). Waardenburg syndrome. Journal of the European Academy of Dermatology and Venereology, 15 (4), 330−333.
1.2.
2001
Kukk, T.; Poder, A.; Kangur, A.; Silm, H. (2001). Dermatovenerological service in Estonia. Forum for Nordic Dermato-Venereology, 6-2, 50.
1.3.
2001
Silm, H. (2001). Professor Aleksandr Paldrock - Eesti dermatoveneroloogia koolkonna rajaja. Eesti Arst, Lisa 2, 27−29.
1.3.
2001
Eisen, M.; Kaur, S.; Silm, H. (2001). The role of domestic allergens in the development of contact dermatitis. Bulletin of dermatology and venerology, 1, 33−36.
3.1.
2001
Silm, H.; Karelson, M.; Kingo, K. (2001). Mentax 1% Cream in Treatment of Tinea Pedum and Tinea Inguinalis. Skin and Environment - Perception and Protection, 1-2: 10th Congress of the European Academy of Dermatology and Venereology; Munich, Germany; October 10-14, 2001. Ed. Ring, J.; Weidinger, S.; Darsow, U. Bologna: Monduzzi Editore, 281−284.
3.3.
2001
Napritson, K.; Raudsepp, H.; Uusküla, A.; Kukk, T.; Kangur, A.; Karelson, M.; Lehtmets, A.; Rajangu, H.; Silm, H. (2001). Akne ravijuhend. Lege Artis (24−26).. Tallinn: Lege Artis.
5.2.
2001
Silm, H.; Karelson, M. (2001). Mentax 1% cream in treatment of tinea pedum ET inguinalis. Journal of the European Academy of Dermatology and Venereology (JEADV), 15, Suppl. 2: 10th Congress of the European Academy of Dermatology; Munich, Germany; 10-14 October 2001. 123.
5.2.
2001
Silm, H.; Kingo, K.; Väli, M.; Karelson, M. (2001). Alopecia areata in assocation with thyroid diseases. Pediatric Dermatology, 18 (4): Annual Meeting of the Society for Pediatric Dermatology. 98.
5.2.
2001
Abram, K.; Kerner, K.; Silm, H.; Rajangu, H. (2001). Psychogenic panniculitis in a 15-year-old girl with mental retardation. Journal of the European Academy of Dermatology and Venereology (JEADV), 15, Suppl. 2: 10th Congress of the European Academy of Dermatology; Munich, Germany; 10-14 October 2001. 255−256.
1.3.
2000
Uusküla, A.; Silm, H. (2000). Genitaalsed mükoplasmainfektsioonid. Eesti Arst, 5, 282−286.
5.2.
2000
Silm, H.; Karelson, M.; Kingo, K. (2000). The factors promoting the developing of lichen planus in Estonia. Baltic association of dermatovenereology 3rd congress; Riga, Latvia; September 7-9, 2000. 90.
5.2.
2000
Kingo, K.; Abram, K.; Silm, H. (2000). Pemphigus herpetiformis - the new pemphigus variant. Journal of the European Academy of Dermatology and Venereology, 14, Suppl. 1: 9th Congress of the European Academy of Dermatology and Venereology; 11-15 October 2000; Geneva, Switzerland. , 195.
1.2.
1999
Kaur, S; Eisen, M; Silm, H. (1999). Results of Patch Testing with European STandard Allergens in Estonia. Forum for Nordic Dermato-Venereology, 2, 9−14.
5.2.
1999
Volke, A.; Silm, H.; Thestrup-Pedersen, K. (1999). Atoopilise dermatiidi haigete nahast pärinevate T-lümfotsüütide vähene reaktiivsus S. aureus'e enterotoksiin A stimulatsioonil. Arstiteaduskonna aastakonverents, 7. oktoober 1999 : teesid. Tartu, 148.
6.6.
1999
Põder, A.; Uusküla, A.; Vendirevskih, G.; Silm, H.; Raukas, E.; Brilene, T. (1999). Meeste uretriidi ja naiste endotservitsiidi/kolpiidi etioloogiline struktuur Eestis. Eesti Naistearstide Seltsi Teataja, 9, 36−41.
6.7.
1999
Silm, H.; Kaur, S. (1999). Dermatoloogia perearstile. . Tartu: Repromill.
1.2.
1998
Kaur, S.; Eisen, M.; Silm, H. (1998). Prevalence of allergic reactions in patients patchtested in Estonia. In: Journal of the European Academy of Dermatology and Venereology.. Nice: Elsevier Science BV.
1.3.
1998
Kaur, S.; Rannala-Lille, T.; Silm, H. (1998). Küünte seenhaiguse orungaal-pulssteraapia. Eesti Arst, 5, 428−432.
1.3.
1998
Kaur, S.; Rannala-Lille, T.; Silm, H. (1998). Küünte seenhaiguse orungaal-pulssteraapia. Eesti Arst, 5, 428-432.
3.5.
1998
Silm, H.; Karelson, M.; Kaur, S.; Kingo, K. (1998). Lichen ruber Eestis. Arstiteaduskonna aastakonverents (72).. Tartu: TÜ Arstiteaduskond.
5.2.
1998
Kaur, S.; Eisen, M.; Silm, H. (1998). Sensitization to common consumer goods allergens is becoming a problem. ESCD. 105.
5.2.
1998
Silm, H.; Kaur, S.; Karelson, M.; Kingo, K. (1998). The factors that promote developing lichen ruber planus in Estonia. Journal of the European Academy of Dermatology and Venereology, 11, Suppl. 2: 7th Congress European Academy of Dermatology and Venereology; France, Nice; 7-11 October 1998. Nice: Elsevier Science BV, S253.
6.2.
1998
Silm, H.; Kaur, S.; Karelson, M. (1998). Viirusinfektsioonid, reaktiivsed erüteemid, villilised dermatoosid. . Tartu: Atlex.
6.6.
1998
Kaur, S.; Silm, H.; Vindirevskih, G.; Sevtsuk, O. (1998). Usoversenstvovanie metodov diagnostiki sifilisa pri pomostsi opredelenija antitel k spezifitseskim belkam vozbuditelja. (21-22).. Moscow: Venera-press.
1.1.
1997
Uuskula, A.; Silm, H.; Vessin, T. (1997). Sexually transmitted diseases in Estonia: Past and present. International Journal of STD & Aids, 8 (7), 446−450.
1.1.
1977
Vahter, H.; Silm, H. (1977). Changes in cholinesterase activity and catecholamine levels in blood-plasma in patients with dermatomycoses. Dermatologische Monatsschrift, 163 (10), 819−824.
6.09.2021

Helgi Silm

https://www.etis.ee/CV/Helgi_Silm/eng
731 9700
helgi.silm@ut.ee

Career

Institutions and positions
01.09.2010–...   
University of Tartu, Faculty of Medicine, Department of Dermatology, Chair of Dermatology and Venerology, Professor emeritus (1,00)
01.01.2016–31.08.2017   
University of Tartu, Faculty of Medicine, Institute of Clinical Medicine, Senior Research Fellowof Dermatology and Venereology (0,50)
01.09.2014–31.12.2015   
University of Tartu, Faculty of Medicine, Department of Dermatology, Senior Research Fellowof Dermatology and Venereology (0,50)
01.09.2011–31.08.2014   
University of Tartu, Faculty of Medicine, Department of Dermatology, Senior Research Fellowof Dermatology and Venereology (0,50)
01.09.2008–31.08.2010   
University of Tartu, Faculty of Medicine, Department of Dermatology, Professor of Dermatology and Venerology (0,50)
01.09.2008–31.08.2011   
University of Tartu, Faculty of Medicine, Department of Dermatology, Senior Research Fellow (0,50)
01.09.2008–31.08.2010   
University of Tartu, Faculty of Medicine, Department of Dermatology, Head of Clinic
01.09.2005–31.08.2008   
University of Tartu, Faculty of Medicine, Department of Dermatology, Head of Clinic
01.09.2003–31.08.2008   
University of Tartu, Faculty of Medicine, Department of Dermatology, Professor (1,00)
01.09.2002–31.08.2005   
University of Tartu, Faculty of Medicine, Department of Dermatology, Head of Clinic
 
 
Education
The Medical Faculty of Tartu University – 1966,
Postgraduate student at Tartu University 1966-1971
 
 
R&D related managerial and administrative work
2006−...   
Member of the Board of the Society For Estonian Dermatologists and Venereologists
1993−...   
Head of the Dermatology Clinic of the Hospital of Tartu University,
Vice President of the Baltic Association of the Dermatologists and Venereologists,
member of the European Academy of Dermatology,
member of International World Society of STD/HIV Infections,
member of the Central and East European Dermatovenereologists Association,
member of the European Union of Medical Specialists(UEMS)
member of European Dermatology Forum(EDF)
member of the Estonian Union against Sexually Transmitted Infections,
member of the Commission of Dermatologists and Venereologists of Estonian Ministry of Social Affairs,
Chairman of the Estonian Commission of Certification of Dermatologists and Venereologists,
Honorary member of the Finish Society of Dermatologists and Venereologists.
Honorary member of the Italian Society of Dermatologists, venereologists
As the President of the Estonian Society for Dermatologists and Venereologists my assignment is to organize scientific conferences of Estonian dermatovenereologists (4 per year).
As Vice President of the Baltic Association of Dermatologists and venereologists I was the member of the organizing committee of 3rd Baltic Congress of Dermatologists and Venereologists. My responsibility was to organize Baltic Congresses of Dermatovenereologists
1984−2010   
member of the Council of the Medical Faculty of the Tartu University

Qualifications

Academic degrees
Helgi Silm, Doctor's Degree, 1971, (sup) -, Naha funktsionaalse seisundi,vereseerumi katehoolamiinideja koliinesteraasi aktiivsuse muutustest epiderma-ja trihhomükoosi haigeil, University of Tartu.
 
 
Additional information
Cand. Med. Sci. (Ph.D.) –
1971 Tartu University,
diploma obtained from Moscow 1972.

Completed projects

Supervised dissertations

Publications

Category
Year
Publication
 
1.1.
2016
Traks, Tanel; Karelson, Maire; Reimann, Ene; Rätsep, Ranno; Silm, Helgi; Vasar, Eero; Kõks, Sulev; Kingo, Külli (2016). Association analysis of class II cytokine and receptor genes in vitiligo patients. Human Immunology, 77 (5), 375−381.10.1016/j.humimm.2015.09.050.
1.2.
2016
Reimann, Ene; Kingo, Külli; Karelson, Maire; Reemann, Paula; Vasar, Eero; Silm, Helgi; Kõks, Sulev (2016). Whole Transcriptome Analysis (RNA Sequencing) of Peripheral Blood Mononuclear Cells of Vitiligo Patients. Dermatopathology, 1 (1), 11−23. DOI: 10.1159/000357402.
1.1.
2015
Keermann, Maris; Kõks, Sulev; Reimann, Ene; Abram, Kristi; Erm, Triin; Silm, Helgi; Kingo, Külli (2015). Expression of IL-36 family cytokines and IL-37 but not IL-38 is altered in psoriatic skin. Journal of Dermatological Science, 80 (2), 150−152. DOI: 10.1016/j.jdermsci.2015.08.002.
1.1.
2014
Reemann, P.; Reimann, E.; Ilmjärv, S.; Porosaar, O.; Silm, H.; Jaks, V.; Vasar, E.; Kingo, K.; Kõks, S. (2014). Melanocytes in the skin - comparative whole transcriptome analysis of main skin cell types. PLoS ONE, 9 (12), e115717. DOI: 10.1371/journal.pone.0115717.
1.1.
2014
Reemann, Paula; Reimann, Ene; Suutre, Siim; Paavo, Maarjaliis; Loite, Ulvi; Porosaar, Orm; Abram, Kristi; Silm, Helgi; Vasar, Eero; Koks, Sulev; Kingo, Kuelli (2014). Expression of Class II Cytokine Genes in Children's Skin. Acta Dermato Venereologica, 94 (4), 386−392. DOI: 10.2340/00015555-1717.
1.1.
2013
Karelson, M.; Silm, H.; Kingo, K. (2013). Quality of Life and Emotional State in Vitiligo in an Estonian Sample: Comparison with Psoriasis and Healthy Controls. Acta Dermato Venereologica, 93, 446−450.
1.1.
2013
Prans, Ele; Kingo, Külli; Traks, Tanel; Silm, Helgi; Vasar, Eero; Kõks, Sulev (2013). Copy number variations in IL22 gene are associated with psoriasis vulgaris. Human Immunology, 74 (6), 792−795.10.1016/j.humimm.2013.01.006.
1.1.
2013
Loite, U; Kingo, K; Reimann, E; Reemann, P; Vasar, E; Silm, H; Kõks, S. (2013). Gene Expression Analysis of the Corticotrophin-releasing Hormone-proopiomelanocortin System in Psoriasis Skin Biopsies. Acta Dermato Venereologica, 93 (4), 400−405. DOI: 10.2340/00015555-1524.
1.1.
2012
Karelson, M.; Silm, H.; Kingo, K. (2012). Quality of Life and Emotional State in Vitiligo in an Estonian Sample: Comparison with Psoriasis and Healthy Controls. Acta Dermato Venereologica, 00.
1.1.
2012
Karelson, M.; Silm, H.; Salum, T.; Kõks, S.; Kingo, K. (2012). Differences between familial and sporadic cases of vitiligo. Journal of the European Academy of Dermatology and Venereology, 26 (7), 915−918. DOI: 10.1111/j.1468-3083.2011.04131.x.
1.1.
2012
Douroudis, K.; Kingo, K.; Traks, T.; Reimann, E.; Raud, K.; Rätsep, R.; Mössner, R.; Silm, H.; Vasar, E.; Kõks, S. (2012). Polymorphisms in the ATG16L1 Gene are Associated with Psoriasis Vulgaris. Acta Dermato Venereologica, 92 (1), 85−87. DOI: 10.2340/00015555-1183.
1.1.
2012
Reimann, E.; Kingo, K.; Karelson, M.; Reemann, P.; Loite, U.; Sulakatko, H.; Keermann, M.; Raud, K.; Abram, K.; Vasar, E.; Silm, H.; Kõks, S. (2012). The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells. Human Immunology, 73 (4), 393−398. DOI: 10.1016/j.humimm.2012.01.011.
1.1.
2012
Reimann, E.; Kingo, K.; Karelson, M.; Reemann, P.; Loite, U.; Keermann, M.; Abram, K.; Vasar, E.; Silm, H.; Kõks, S. (2012). Expression profile of genes associated with the dopamine pathway in vitiligo skin biopsies and blood sera. Dermatology, 224 (2), 168−176. DOI: 10.1159/000338023.
4.2.
2012
Altmets, Mait; Altraja, Alan; Ambos, Anu; Andresen, Kadri; Arumäe, Katrin; Brachinsky, Mark; Elmet, Märt; Haldre, Sulev; Hedman, Anu; Kahu, Jaanus; Kaljusaar, Heli; Kallikorm, Riina; Karelson, Maire; Karjagin, Juri; Kaur, Sirje; Kingo, Külli; Koorits, Ursula; Kull, Karin; Kõrv, Janika; Linnamägi, Ülla ... Uuetoa, Tiina (2012). Eakate farmakoteraapia [Pharmacotherapy in the elderly]. Tallinn: Medicina.
5.2.
2012
Karelson, M.; Silm, H.; Kingo, K. (2012). Vitiliigohaigete elukvaliteedi ja emotsionaalse seisundi võrdlus psoriaasihaigete ning tervete vabatahtlikega. Eesti Arst: TÜ arstiteaduskonna aastapäeva teaduskonverents, Tartu, oktoober 2012. 23−23.
1.1.
2011
Douroudis, K.; Kingo, K.; Traks, T.; Rätsep, R.; Silm, H.; Vasar, E.; Kõks, S. (2011). ATG16L1 gene polymorphisms are associated with palmoplantar pustulosis. Human Immunology, 72 (7), 613−615.
1.1.
2011
Douroudis, K.; Kingo, K.; Karelson, M.; Silm, H.; Reimann, E.; Traks, T.; Vasar, E.; Kõks, S. (2011). The PRO2268 gene as a novel susceptibility locus for vitiligo. Acta Dermato Venereologica, 91 (2), 189−191. DOI: 10.2340/00015555-0999.
5.2.
2011
Karelson, Maire; Silm, Helgi; Salum, Tiit; Kõks, Sulev; Kingo, Külli (2011). Differences between familial and sporadic cases of vitiligo. Eesti Arst: Arstiteaduskonna päevad, Tartu, 13-14.okt.2011. 22−22. (90, lisa1).
1.1.
2010
Douroudis, K.; Kingo, K.; Silm, H.; Reimann, E.; Traks, T.; Vasar, E.; Kõks, S. (2010). The CD226 Gly307Ser gene polymorphism is associated with severity of psoriasis. Journal of Dermatological Science, 58, 160−161. DOI: 10.1016/j.jdermsci.2010.03.015.
1.1.
2010
Kõks, Sulev; Kingo, Külli; Mössner, Rotraut; Rätsep, Ranno; Krüger, Ullrich; Silm, Helgi; Vasar, Eero; Reich, Kristian; Raud, Kristi; Traks, Tanel; Reimann, Ene (2010). Further association analysis of chr 6q22-24 suggests a role of IL-20RA polymorphisms in psoriasis. Journal of Dermatological Science, 57 (1), 71−73. DOI: 10.1016/j.jdermsci.2009.10.007.
1.1.
2010
Kingo, K.; Reimann, E.; Karelson, M.; Rätsep, R.; Raud, K.; Vasar, E.; Silm, H.; Kõks, S. (2010). Association analysis of genes of the IL19 cluster and their receptors in vitiligo patients. Dermatology, 221 (3, 10), 261−266. DOI: 10.1159/000317526.
1.1.
2010
Philips, M-A; Kingo, K; Karelson, M; Rätsep, R; Aunin, E; Reimann, E; Reemann, P; Porosaar, O; Vikeså, J; Nielsen, F; Vasar, E; Silm, H; Kõks, S. (2010). Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1. BMC Medical Genetics, 56. DOI: 10.1186/1471-2350-11-56.
1.1.
2010
Reimann, E.; Kingo, K.; Karelson, M.; Salum, T.; Aunin, E.; Reemann, P.; Abram, K.; Vasar, E.; Silm, H.; Kõks, S. (2010). Analysis of the expression profile of CRH-POMC system genes in vitiligo skin biopsies. Journal of Dermatological Science, 60 (2), 125−128. DOI: 10.1016/j.jdermsci.2010.08.004.
1.1.
2010
Abram, K.; Silm, H.; Maaroos, HI.; Oona, M. (2010). Risk factors associated with rosacea. Journal of the European Academy of Dermatology and Venereology, 24 (5), 565−571. DOI: 10.1111/j.1468-3083.2009.03472.x.
1.1.
2010
Abram, K.; Silm, H.; Oona, M. (2010). Prevalence of rosacea in an Estonian working population using a standard classification. Acta Dermato Venereologica, 90 (3), 269−273. DOI: 10.2340/00015555-0856.
5.2.
2010
Reimann, E.; Reemann, P.; Lilleoja, R.; Jaakma, Ü.; Kingo, K.; Vasar, E.; Silm, H.; Kõks, S. (2010). Whole transcriptome RNA-Seq of human dermal fibroblasts using SOLiD system. CRG Symposium: "Medical Genome Sequencing: Understanding the Genomes of Disease", Barcelona, Spain, 28.-29.10.2010.
6.2.
2010
Kaur, Sirje; Silm, Helgi; Kingo, Külli; Karelson, Maire; Abram, Kristi. (2010). Nahahaigused [Skin diseases]. Eesti, Tartu ülikooli kirjastus: University of Tartu.
1.1.
2009
Abram, K.; Silm, H.; Maaroos, H.-I.; Oona, M. (2009). Subjective disease perception and symptoms of depression in relation to healthcare-seeking behaviour in patients with rosacea. Acta Dermato Venereologica, 89 (5), 488−491.
1.2.
2009
Karelson, M.; Kingo, K.; Salum, T.; Kõks, S.; Silm, H. (2009). An Adult´s Vitiligo in Estonia: Study of 155 patients. The Open Dermatology Journal, 3, 68−72.
5.1.
2009
Abram, K.; Silm, H.; Maaroos, H.-I.; Oona, M. (2009). Risk Factors Associated for Rosacea. Helicobacter, 14: 22nd International Workshop on Helicobacter and Related Bacteria in Chronic Digestive Inflammation and Gastric Cancer, SEP 17-19, 2009 Opotro, PORTUGAL. 367. (4).
5.1.
2009
Abram, K.; Silm, H.; Maaroos, HI. (2009). Risk factors associated with rosacea. Helicobacter 14(4): 22nd International Workshop on Helicobacter and Related Bacteria in Chronic Digestive Inflammation and Gastric Cancer; Opotro, Portugal; 17-19, September 2009. 367.
5.2.
2009
Abram, K.; Silm, H.; Maaroos, H.-I.; Oona, M. (2009). Rosaatseaga seotud riskifaktorid. Eesti Arst, 88: TÜ Arstiteaduskonna päevad 2009, Dorpati konverentsikeskus, 8-9 oktoober.. 621. (9).
5.2.
2009
Abram, K.; Silm, H.; Oona, M. (2009). Prevalence of rosacea in general population according to the national rosacea society expert committee. 90: Final Programme 6th EADV Spring Symposium; Bucharest, Romania; April 23-26, 2009. 269−273.
1.1.
2008
Kingo, K.; Aunin, E.; Karelson, M.; Rätsep, R.; Silm, H.; Vasar, E.; Kõks, S. (2008). Expressional changes in the intracellular melanogenesis pathways and their possible role in the pathogenesis of vitiligo. Journal of Dermatological Science, 52 (1), 39−46. DOI: 10.1016/j.jdermsci.2008.03.013.
1.1.
2008
Kingo, K.; Mössner, R.; Rätsep, R.; Raud, K.; Krüger, U.; Silm, H.; Vasar, E.; Reich, K.; Kõks, S. (2008). Association analysis of IL20RA and IL20RB genes in psoriasis. Genes and Immunity, 9 (5), 445−451. DOI: 10.1038/gene.2008.36.
1.1.
2008
Rätsep, R.; Kingo, K.; Karelson, M.; Reimann, E.; Raud, K.; Silm, H.; Vasar, E.; Kõks, S. (2008). Gene expression study of IL10 family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera. British Journal of Dermatology, 159 (6), 1275−1281. DOI: 10.1111/j.1365-2133.2008.08785.x.
1.3.
2008
Kangur, A.; Põder, A.; Maimets, M.; Silm, H.; Kukk, T.; Uusküla, A.; Rajangu, H.; Brilene, T.; Zilmer, K.; Saarma, I.; Karro, H.; Tammemäe, L.; Szirko, F.; Timberg, G.; Punab, M.; Kallikorm, R. (2008). STList vallandunud reaktiivne artriit. Eesti Arst, 87 (3), 231−241.
5.1.
2008
Abram, K.; Oona, M.; Silm, H.; Maaroos, H.-I. (2008). Trends of the Prevalence of H. pylori in Adults in Estonia. Helicobacter, 13: 1st International Workshop on Helicobacter and Related Bacteria in Chronic Digestive Inflammation and Gastric Cancer; Riga, LATVIA; SEP 18-20, 2008. 429. (5).
5.2.
2008
Karelson, M.; Kingo, K.; Silm, H. (2008). Vitiliigo kliinilised vormid ja nende avaldumine. Eesti Arst, 87: TÜ Arstiteaduskonna päevad; Tartu; 9-10.okt 2008. OÜ Celsius Healthcare, 668−668. (9).
5.2.
2008
Abram, K.; Oona, M.; Maaroos, H.-I.; Silm, H. (2008). Depressive symptoms and disease perception among rosacea patients. 17th Congress of the European Academy of Dermatology and Venerology (EADV 2008); Paris; 17-21 September 2008.
5.2.
2008
Abram, K.; Oona, M.; Maaroos, H.-I.; Silm, H. (2008). Helicobacter pylori infektsiooni levimus täiskasvanutel. Eesti Arst, 87(9): TÜ Arstiteaduskonna teaduskonverents, 09.10.2008 Tartu. 674.
6.7.
2008
Silm, Helgi; Kõks, Sulev; Kingo, Külli; Rätsepp, Ranno; Kaur, Sirje; Abram, Kristi; Pärna, Ene; Kingo, Külli; Karelson, Maire (2008). Kliinik 2008 : psoriaasi patogenees ja ravi - kaasaegsed arengusuunad TÜ Nahahaiguste Kliinikus [Videosalvestis]. Kliinik 2008, Tartu Ülikooli Kliinikumi täienduskonverents; Tartu; 4. - 6. veebruar, 2008. Tartu: TÜ IT Multimeedia talitus,. (TÜ filmiarhiiv).
1.1.
2007
Kingo, K.; Mossner, R.; Koks, S.; Ratsep, R.; Kruger, U.; Vasar, E.; Reich, K.; Silm, H. (2007). Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis. British Journal of Dermatology, 156 (4), 646−652. DOI: 10.1111/j.1365-2133.2006.07731.x.
1.1.
2007
Kingo, K.; Aunin, E.; Karelson, M.; Philips, MA; Rätsep, R.; Silm, H.; Vasar, E.; Soomets, U.: Kõks S. (2007). Gene expression analysis of melanocortin system in vitiligo. Journal of Dermatological Science, 48 (2), 113−122.
1.3.
2007
Kangur, A.; Põder, A.; Maimets, M.; Silm, H.; Kukk, T.; Uusküla, A.; Rajangu, H.; Brilene, T.; Zilmer, K.; Saarma, I.; Karro, H.; Tammemäe, L.; Szirko, F.; Timberg, G.; Punab, M.; Kallikorm, R. (2007). Seksuaalsel teel levivate infektsioonide Eesti ravijuhend 2007. I. Omandatud süüfilis. Eesti Arst, 86 (10), 770−777.
1.3.
2007
Abram, K.; Oona, M.; Silm, H. (2007). Rosaatsea ja perioraalne dermatiit. Eesti Arst, 86 (10), 729−735.
3.2.
2007
Kõks, S.; Kingo, K.; Vasar, E.; Silm, H. (2007). Interleukin-20. In: Zdanov, A. (Ed.). Class II Cytokines (145−160).. Research Signpost.
5.2.
2007
Karelson, M.; Kingo, K.; Kõks, S.; Silm, H.; Vasar, E.; Salum, T. (2007). Coexistence of vitiligo and autoimmune disorders in Estonia. Abstract Book: 21 World Congress of Dermatology, Buenos Aires, Argentina, 01-05.oct,2007. 344.
5.2.
2007
Kingo, K.; Raud, K.; Rätsep, R.; Kõks, S.; Silm, H.; Vasar, E. (2007). The gene expression of Interleukin-22 in plaque psoriasis. Abstract Book: 21 World Congress of Dermatology; Buenos Aires, Argentina; 01-05.oct. 2007. 203.
5.2.
2007
Karelson, M.; Kingo, K.; Kõks, S.; Vasar, E.; Salum, T.; Silm, H. (2007). Autoimmuunhaiguste kaasnemine ja autoantikehade esinemine vitiliigo haigetel. Eesti Arst, 86, 691.
5.2.
2007
Pärna, E.P.; Abram, K.; Kingo, K.; Oona, M.; Silm, H. (2007). Emotional status in psoriasis patients in relation to the sevsrity of disorder. 12th Congress of the European Society for Dermatology and Psychiatry, Wroclaw, Poland, June 14th-17th, 2007. 46.
5.2.
2007
Pärna, E.; Abram, K.; Kingo, K.; Oona, M.; Silm, H. (2007). Psoriaasihaigete emotsionaalne enesetunne sõltuvalt haiguse raskusest. Eesti Arst, 689−690.
5.2.
2007
Abram, K.; Oona, M.; Silm, H.; Maaroos, H.-I. (2007). Rosaatsea seosed Helicobacter pylori infektsiooniga. Eesti Arst, 86: Õppejõudude, teadurite, doktorantide, magistrantide ja üliõpilaste teaduskonverents 18. oktoobril 2007 TÜ Biomeedikumis. Eesti Arst, 675. (9).
1.1.
2006
Kingo, K.; Philips, M.A.; Aunin, E.; Luuk, H.; Karelson, M.; Ratsep, R.; Silm, H.; Vasar, E.; Kõks, S. (2006). MYG1, novel melanocyte related gene, has elevated expression in vitiligo. Journal of Dermatological Science, 44 (2), 119−122.
1.3.
2006
Karelson, M.; Kingo, K.; Silm, H. (2006). Vitiliigo - mis on teada tänasel päeval? Eesti Arst, 85 (7), 438−444.
3.1.
2006
Kõks, S.; Kingo, K.; Vasar, E.; Silm, H. (2006). Interleukin-19 subfamily of cytokines. In: Vandenbroeck, K. (Ed.). Cytokine Gene Polymorphisms in Multifactorial Conditions (147−155).. CRC Press Inc.
3.1.
2006
Kõks, S.; Kingo, K.; Vasar, E.; Silm, H. (2006). Psoriasis and cytokine polymorphisms. In: Vandenbroeck, K. (Ed.). Cytokine Gene Polymorphisms in Multifactorial Conditions (321−335).. CRC Press Inc.
3.4.
2006
Abram, K.; Silm, H.; Oona, M. (2006). Smoking habits among patients with Rosacea. From Hippocrates to Modern Dermatology 15th EADV Congress; Rhodes, Greece; 4-8 October, 2006. Mediamond, 639−642.
5.2.
2006
Silm, H. (2006). Update in Treatment of Pyoderma. Precise diagnostics - foundation for a succesful skin and STD theray: BADV 6th Congress; Läti, Riia; 14 - 16 september 2006. _EditorsAbbr Rubins, A. Läti: Latvia, 30.
5.2.
2006
Kingo, K.; Karelson, M.; Aunin, E.; Silm, H.; Vasar, E.; Kõks, S. (2006). Regulation of the cutaneous corticotropin releasing hormone - proopiomelanocortin systemin vitiligo. BADV 6th Congress; Latvia, Riga; 14 - 16 September, 2006. Ed. Rubins, A. Läti, Riia: Latvia, 41.
5.2.
2006
Kingo, K.; Karelson, M.; Aunin, E., Kõks, S.; Vasar, E.; Silm, H. (2006). Expression of Genes of Melanocortin system in Vitiligo. Dermatovenerologie, 51 (3): National Congress of Dermatology with Intyernational Participation. The XIIth ALP-Danube-Adria STD conference; 1- 4 november, 2006. Rumeenia, 2. (Suppl. 1).
5.2.
2006
Rätsep, R.; Karelson, M.; Kingo, K.; Aunin, E.; Kõks, S.; Silm, H.; Vasar, E. (2006). Interleukiinide ja nende retseptorite ekspressioon vitiliigoga patsientide ja kontrollgrupi nahas. Eesti Arst, 85(9): TÜ arstiteaduskonna teaduskonverents; Tartu; 13. oktoober 2006. 618.
5.2.
2006
Philips, M.-A.; Kingo, K.; Kõks, S.; Aunin, E.; Karelson, M.; Silm, H.; Vasar, E. (2006). Myg1 protein is functionally important in both brain and skin. FENS Forum Abstracts, 3: 5th Forum of European Neuroscience; Vienna, Austria; 08 - 12 July, 2006.
5.2.
2006
Raud, K.; Kingo, K.; Ehrlich, K.; Kõks, S.; Silm, H.; Vasar, E.; Soomets, U. (2006). Glutatsioonisüsteemi regulatsioon psoriaasi korral. Eesti Arst, 85 (9): Arstiteaduskonna päevad 2006. 633−634.
5.2.
2006
Kingo, K.; Aunin, E.; Karelson, M.; Rätsep, R.; Philips, M.A.; Luuk, H.; Kõks, S.; Silm, H.; Vasar, E. (2006). Melanokortiini - süsteem ja vitiliigo. Eesti Arst, 85 (9): TÜ arstiteaduskonna teaduskonverents; Tartu; 13.10.2006. , 647.
6.3.
2006
Silm, H. (2006). Morfea ehk Scleroderma circumscripta. Lege Artis, 25−26.
1.1.
2005
Mossner, R.; Kingo, K.; Kleensang, A.; Kruger, U.; Konig, IR.; Silm, H.; Westphal, GA.; Reich, K. (2005). Association of TNF-238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris. The Journal of Investigative Dermatology, 124 (1), 282−284.
1.1.
2005
Koks, S.; Kingo, K.; Vabrit, K.; Ratsep, R.; Karelson, M.; Silm, H.; Vasar, E. (2005). Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis. Genes and Immunity, 6 (5), 407−415.
1.1.
2005
Kingo, K.; Ratsep, R.; Koks, S.; Karelson, M.; Silm, H.; Vasar, E. (2005). Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility. Journal of Dermatological Science, 37 (2), 111−113.
1.1.
2004
Koks, S.; Kingo, K.; Ratsep, R.; Karelson, M.; Silm, H.; Vasar, E. (2004). Combined haplotype analysis of the interleukin-19 and-20 genes: relationship to plaque-type psoriasis. Genes and Immunity, 5 (8), 662−667.
1.1.
2004
Kingo, K.; Koks, S.; Nikopensius, T.; Silm, H.; Vasar, E. (2004). Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis. Genes and Immunity, 5 (2), 117−121.
1.1.
2004
Järv, H.; Naaber, P.; Kaur, S.; Eisen, M.; Silm, H. (2004). Screening of toenail onychomycosis in Estonia. Mycoses, 47, 57−61.
1.3.
2004
Kukk, T.; Raudsepp, H.; Tampere, M.; Skalkina, A.; Aluoja, A.; Kirsimägi, Ü.; Silm, H. (2004). Raske akne ravi süsteemse retinoidiga (isotretinoinum). Emotsionaalse enesetunde muutumine ravi käigus. Eesti Arst, 83 (10), 659−665.
5.2.
2004
Rätsep, R.; Kingo, K.; Kõks, S.; Karelson, M.; Silm, H.; Vasar, E. (2004). Interleukiin-19 ja interleukiin-20 geenide haplotüüpide efektid psoriaasi avaldumisele. 625.
5.2.
2004
Kingo, K.; Rätsep, R.; Kõks, S.; Karelson, M.; Silm, H.; Vasar, E. (2004). Genetic influence on IL-10 expression of patients with plaque type psoriasis. Journal of the European Academy of Dermatology and Venereology, 18 (Suppl. 2), 337.
5.2.
2004
Kingo, K.; Rätsep, R.; Kõks, S.; Karelson, M.; Silm, H.; Vasar, E. (2004). Association between interleukin-19 and interleukin-20 genetic polymorphisms and plaque-type psoriasis. 16th Congress of Latvian Association of Dermatovenerologists, "Latest Achievements in Skin and Sexually Transmitted Diseases Diagnostics and Therapy"; Riga, Latvia; September 10-11, 2004.
1.1.
2003
Kingo, K.; Koks, S.; Silm, H.; Vasar, E. (2003). IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes and Immunity, 4 (6), 455−457.
1.3.
2003
Volke, A.; Silm, H. (2003). Atoopiline dermatiit on enam kui lihtsalt allergia. Eesti Arst, 82 (6), 416−422.
3.1.
2003
Vasar, E.; Kõks, S.; Kingo, K.; Karelson, M.; Silm, H. (2003). Promoter polymorphism at position-592 of the interleukin-10 is not associated with early- and late-onset psoriasis. Journal of the European Academy of Dermatology and Venereology, 16, Supplement 1: 11th Congress of the European Academy of Dermatology and Venereology. 2-6 October 2002, Prague, Czech Republic. Bologna: Monduzzi Editore, 303−306.
3.3.
2003
Põder, A.; Maimets, M.; Silm, H.; Kangur, A.; Kukk, T.; Uusküla, A.; Rajangu, H. (2003). Seksuaalsel teel levivate infektsioonide ravijuhis Eestis. Tallinn: STLIEÜ.
3.4.
2003
Karelson, M.; Kürsa, V.; Kingo, K.; Silm, H. (2003). Teleangiectasia macularis eruptiva perstans. 11th Congress of the European Academy of Dermatology and Venereology; Prague, Czech Republic; 2-6 October 2002. 93−95.
5.2.
2003
Kingo, Külli; Kõks, Sulev; Silm, Helgi; Vasar, Eero (2003). Interleukiin-20 geneetiliste polümorfismide seos psoriaasiga. Eesti Arst, 9, 631.
5.2.
2003
Kingo, K.; Kõks, S.; Silm, H.; Vasar, E. (2003). Polymorphism in the promoter region of the interleukin-20 gene - relationship to psoriasis vulgaris. Journal of the European Academy of Dermatology and Venereology, 17, Suppl. 3, 378.
6.2.
2003
Kaur, S.; Silm, H. (2003). Nakkuslikud nahahaigused: õppevahend üliõpilastele ja arstidele. Tartu: Tartu Ülikooli Kirjastus.
6.6.
2003
Silm, H. (2003). Balti Dermatoveneroloogide Assotsiatsioon. Eesti Arst, 10, 736.
6.6.
2003
Silm, H.; Kingo, K. (2003). Esimesed kogemused psoriaasi ravimisel Daivobet salviga. Hippokrates, 45, 431−434.
1.1.
2002
Silm, H.; Karelson, M. (2002). Terbinafine: efficacy and tolerability in young children with tinea capitis due to Microsporum canis. Journal of the European Academy of Dermatology and Venereology, 16 (3), 228−230.
1.3.
2002
Silm, H.; Paasik, K.; Kingo, K.; Kink, R. (2002). Vaskaurude laser nahahaiguste ravis. Eesti Arst, 81 (7), 406−410.
1.3.
2002
Järv, H.; Naaber, P.; Kaur, S.; Eisen, M.; Silm, H. (2002). Varbaküünte seenhaigus Eestis - võrdlus Euroopa maadega. Eesti Arst, 81 (6), 338−342.
3.1.
2002
Silm, H.; Kerner, K.; Abram, K. (2002). Psychogenic Panniculitis in a 15-year-old Girl with Mental Retardion. Skin and Environment - Perception and Protection, 1-2: 10th Congress of the European Academy of Dermatology and Venereology; Munich, Germany; October 10-14, 2001. _EditorsAbbr Ring, J.; Weidinger, S.; Darsow, U. Bologna: Monduzzi Editore, 205−208.
3.2.
2002
Silm, H.; Karelson, M. (2002). Estonian Society for Dermatologists and Venereologists. In: Hercogova, J.; Delescluse, J.; Lotti, T.M. (Ed.). Millennium Dermatologicum. European handbook of Dermatological Societies (51−52). . Prague: Prague Academy.
3.4.
2002
Kingo, K.; Kõks, S.; Karelson, M.; Silm, H.; Vasar, E. (2002). Promoter polymorphism at position - 592 of the interleukin-10 is not associated with early and late-onset psoriasis. Proceedings 11th EADV Congress Prague 2002 “ More than Skin – deep” of the European Academy of Dermatology and Venerology, 16:1: Scientific Publishing&Communication. International Proceedings Division, 2003. 303−306.
3.4.
2002
Järv, H.; Naaber, P.; Kaur, S.; Eisen, M.; Silm, H. (2002). Clinical, mycological and epidemiological characteristics of toenail onychomycosis in Estonia. Clinical Microbiology and Infection, 8, Suppl. 1: 12th European Congress of Clinical Microbiology and Infectious Diseases; Milan, Italy; 21-24 Aprill 2002. 347−348.
3.5.
2002
Silm, H. (2002). Kaasasündinud süüfilis. Seksuaalsel Teel Levivate Infektsioonide Eesti ühingu IV konverents, Palmse; 14.-15. juuni 2002. Tallinn: STLIEÜ, 74−77.
5.2.
2002
Karelson, M.; Kürsa, V.; Kingo, K.; Silm, H. (2002). Teleangiectasia macularis eruptiva perstans. Journal of the European Academy of Dermatology and Venereology, 16, Suppl. 1: 11th Congress of the European Academy of Dermatology and Venereology. Brussels, 198.
5.2.
2002
Silm, H.; Kingo, K.; Paasik, K.; Kink, R. (2002). The efficiency of copper vapour laser equipment for treatment of patients with rosacea. Annales de Dermatologie et de Venereologie, 129, 1S615.
6.3.
2002
Abram, K.; Silm, H. (2002). Jalgade seenhaiguse ehk Tinea pedum'i ja seenallergiidide tänapäevane ravi. Lege Artis, 1, 5.
6.6.
2002
Silm, H. (2002). Terbinafiin küünte seenhaiguste ravis. Lege Artis, 6, 42−43.
6.6.
2002
Silm, H. (2002). Küüneseenhaiguse ravi laia toimespektriga antimükootikumidega. Lege Artis, 7 (11), 51.
6.6.
2002
Kaur, S.; Lehtmets, A.; Karelson, M.; Kukk, T.; Kangur, A.; Rajangu, H.; Põder, A.; Silm, H. (2002). Urtikaaria ravijuhend. Lege Artis, 10, 20−25.
1.1.
2001
Konno, P.; Silm, H. (2001). Waardenburg syndrome. Journal of the European Academy of Dermatology and Venereology, 15 (4), 330−333.
1.2.
2001
Kukk, T.; Poder, A.; Kangur, A.; Silm, H. (2001). Dermatovenerological service in Estonia. Forum for Nordic Dermato-Venereology, 6-2, 50.
1.3.
2001
Silm, H. (2001). Professor Aleksandr Paldrock - Eesti dermatoveneroloogia koolkonna rajaja. Eesti Arst, Lisa 2, 27−29.
1.3.
2001
Eisen, M.; Kaur, S.; Silm, H. (2001). The role of domestic allergens in the development of contact dermatitis. Bulletin of dermatology and venerology, 1, 33−36.
3.1.
2001
Silm, H.; Karelson, M.; Kingo, K. (2001). Mentax 1% Cream in Treatment of Tinea Pedum and Tinea Inguinalis. Skin and Environment - Perception and Protection, 1-2: 10th Congress of the European Academy of Dermatology and Venereology; Munich, Germany; October 10-14, 2001. Ed. Ring, J.; Weidinger, S.; Darsow, U. Bologna: Monduzzi Editore, 281−284.
3.3.
2001
Napritson, K.; Raudsepp, H.; Uusküla, A.; Kukk, T.; Kangur, A.; Karelson, M.; Lehtmets, A.; Rajangu, H.; Silm, H. (2001). Akne ravijuhend. Lege Artis (24−26).. Tallinn: Lege Artis.
5.2.
2001
Silm, H.; Karelson, M. (2001). Mentax 1% cream in treatment of tinea pedum ET inguinalis. Journal of the European Academy of Dermatology and Venereology (JEADV), 15, Suppl. 2: 10th Congress of the European Academy of Dermatology; Munich, Germany; 10-14 October 2001. 123.
5.2.
2001
Silm, H.; Kingo, K.; Väli, M.; Karelson, M. (2001). Alopecia areata in assocation with thyroid diseases. Pediatric Dermatology, 18 (4): Annual Meeting of the Society for Pediatric Dermatology. 98.
5.2.
2001
Abram, K.; Kerner, K.; Silm, H.; Rajangu, H. (2001). Psychogenic panniculitis in a 15-year-old girl with mental retardation. Journal of the European Academy of Dermatology and Venereology (JEADV), 15, Suppl. 2: 10th Congress of the European Academy of Dermatology; Munich, Germany; 10-14 October 2001. 255−256.
1.3.
2000
Uusküla, A.; Silm, H. (2000). Genitaalsed mükoplasmainfektsioonid. Eesti Arst, 5, 282−286.
5.2.
2000
Silm, H.; Karelson, M.; Kingo, K. (2000). The factors promoting the developing of lichen planus in Estonia. Baltic association of dermatovenereology 3rd congress; Riga, Latvia; September 7-9, 2000. 90.
5.2.
2000
Kingo, K.; Abram, K.; Silm, H. (2000). Pemphigus herpetiformis - the new pemphigus variant. Journal of the European Academy of Dermatology and Venereology, 14, Suppl. 1: 9th Congress of the European Academy of Dermatology and Venereology; 11-15 October 2000; Geneva, Switzerland. , 195.
1.2.
1999
Kaur, S; Eisen, M; Silm, H. (1999). Results of Patch Testing with European STandard Allergens in Estonia. Forum for Nordic Dermato-Venereology, 2, 9−14.
5.2.
1999
Volke, A.; Silm, H.; Thestrup-Pedersen, K. (1999). Atoopilise dermatiidi haigete nahast pärinevate T-lümfotsüütide vähene reaktiivsus S. aureus'e enterotoksiin A stimulatsioonil. Arstiteaduskonna aastakonverents, 7. oktoober 1999 : teesid. Tartu, 148.
6.6.
1999
Põder, A.; Uusküla, A.; Vendirevskih, G.; Silm, H.; Raukas, E.; Brilene, T. (1999). Meeste uretriidi ja naiste endotservitsiidi/kolpiidi etioloogiline struktuur Eestis. Eesti Naistearstide Seltsi Teataja, 9, 36−41.
6.7.
1999
Silm, H.; Kaur, S. (1999). Dermatoloogia perearstile. . Tartu: Repromill.
1.2.
1998
Kaur, S.; Eisen, M.; Silm, H. (1998). Prevalence of allergic reactions in patients patchtested in Estonia. In: Journal of the European Academy of Dermatology and Venereology.. Nice: Elsevier Science BV.
1.3.
1998
Kaur, S.; Rannala-Lille, T.; Silm, H. (1998). Küünte seenhaiguse orungaal-pulssteraapia. Eesti Arst, 5, 428−432.
1.3.
1998
Kaur, S.; Rannala-Lille, T.; Silm, H. (1998). Küünte seenhaiguse orungaal-pulssteraapia. Eesti Arst, 5, 428-432.
3.5.
1998
Silm, H.; Karelson, M.; Kaur, S.; Kingo, K. (1998). Lichen ruber Eestis. Arstiteaduskonna aastakonverents (72).. Tartu: TÜ Arstiteaduskond.
5.2.
1998
Kaur, S.; Eisen, M.; Silm, H. (1998). Sensitization to common consumer goods allergens is becoming a problem. ESCD. 105.
5.2.
1998
Silm, H.; Kaur, S.; Karelson, M.; Kingo, K. (1998). The factors that promote developing lichen ruber planus in Estonia. Journal of the European Academy of Dermatology and Venereology, 11, Suppl. 2: 7th Congress European Academy of Dermatology and Venereology; France, Nice; 7-11 October 1998. Nice: Elsevier Science BV, S253.
6.2.
1998
Silm, H.; Kaur, S.; Karelson, M. (1998). Viirusinfektsioonid, reaktiivsed erüteemid, villilised dermatoosid. . Tartu: Atlex.
6.6.
1998
Kaur, S.; Silm, H.; Vindirevskih, G.; Sevtsuk, O. (1998). Usoversenstvovanie metodov diagnostiki sifilisa pri pomostsi opredelenija antitel k spezifitseskim belkam vozbuditelja. (21-22).. Moscow: Venera-press.
1.1.
1997
Uuskula, A.; Silm, H.; Vessin, T. (1997). Sexually transmitted diseases in Estonia: Past and present. International Journal of STD & Aids, 8 (7), 446−450.
1.1.
1977
Vahter, H.; Silm, H. (1977). Changes in cholinesterase activity and catecholamine levels in blood-plasma in patients with dermatomycoses. Dermatologische Monatsschrift, 163 (10), 819−824.
6.09.2021

Otsi projekti

  • {{item.Name}}
Asutus on projekti finantseerija   Asutus on projekti teostaja  
  • {{searchListItem.Name}}
Kõik   Tavaprojektid   Ülemprojektid   Alamprojektid  
Uus Frascati (2015)
Uus ja vana Frascati (otsing uue järgi väljastab ka seotud vanad)
Kõik
Käimasolevad
Lõppenud
Algus
Hajus
Täpne
Uus otsing (Beetaversioon) Lihtotsing Tühjenda
  • Leitud 6 kirjet
ProgrammLiikNumberNimiProjekti algusProjekti lõppVastutav täitjaAsutusFinantseerijapoolne rahastamine
ETFETF7549Adipokiinide ja neuropeptiidide tähtsus psoriaasi patogeneesis01.01.200831.12.2011Sirje KaurTartu Ülikool, Arstiteaduskond89 272,33 EUR
ETFETF5712Interleukiin-10 perekonna tsütokiinide geenide polümorfismi seosed psoriaasiga01.01.200431.12.2007Helgi SilmTartu Ülikool, Arstiteaduskond43 266,17 EUR
SFSF0180043s07Krooniliste dermatooside patogeneesi molekulaarsed mehhanismid 01.01.200731.12.2012Helgi SilmTartu Ülikool, Arstiteaduskond330 564,92 EUR
SFSF0182128s02Naha- ja suguhaiguste patogeneesi molekulaarsed mehhanismid ja epidemioloogilised aspektid Eestis01.01.200231.12.2006Helgi SilmTartu Ülikool, Arstiteaduskond133 894,91 EUR
PUT; PUT_OPPUT177VITILIIGO PATOGENEESI MOLEKULAARSED MEHHANISMID, T-RAKKUDE ROLL VITILIIGO PATOGENEESIS.01.01.201331.12.2016Külli KingoTartu Ülikool, Meditsiiniteaduste valdkond, kliinilise meditsiini instituut217 440,00 EUR
APSF0180043s07APVäikesemahulise teaduse infrastruktuuri kaasajastamine teadusteema SF0180043s07 raames01.01.201031.12.2011Helgi SilmTartu Ülikool, Arstiteaduskond60 716,00 EUR